Chia‐Chi Wang

1.4k total citations
39 papers, 748 citations indexed

About

Chia‐Chi Wang is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chia‐Chi Wang has authored 39 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 20 papers in Hepatology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chia‐Chi Wang's work include Liver Disease Diagnosis and Treatment (30 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (14 papers). Chia‐Chi Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (14 papers). Chia‐Chi Wang collaborates with scholars based in Taiwan, United States and Australia. Chia‐Chi Wang's co-authors include Jia‐Horng Kao, Tai‐Chung Tseng, Ching‐Sheng Hsu, Pin‐Nan Cheng, Yu‐Ming Cheng, Ding‐Shinn Chen, Chun‐Jen Liu, Pei‐Jer Chen, Chen‐Hua Liu and Ming–Yang Lai and has published in prestigious journals such as Clinical Infectious Diseases, Atherosclerosis and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Chia‐Chi Wang

35 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chia‐Chi Wang Taiwan	14	556	451	102	74	52	39	748
Valéria Pereira Lanzoni Brazil	17	620 1.1×	578 1.3×	58 0.6×	129 1.7×	9 0.2×	64	970
Mustafa Yakut Türkiye	12	291 0.5×	242 0.5×	14 0.1×	154 2.1×	69 1.3×	34	550
Halis Şimşek Türkiye	12	448 0.8×	303 0.7×	83 0.8×	173 2.3×	112 2.2×	20	644
Gonca Tatar Türkiye	12	251 0.5×	88 0.2×	96 0.9×	274 3.7×	113 2.2×	33	545
Daniel Pineda‐Tenor Spain	12	184 0.3×	134 0.3×	34 0.3×	48 0.6×	2 0.0×	45	420
Ahmet Dobrucalı Türkiye	14	112 0.2×	27 0.1×	37 0.4×	357 4.8×	126 2.4×	31	537
Tércio Genzini Brazil	13	97 0.2×	124 0.3×	70 0.7×	370 5.0×	4 0.1×	66	492
Fumi Varyani United Kingdom	9	87 0.2×	45 0.1×	333 3.3×	156 2.1×	8 0.2×	13	784
Yoshiyasu Kato Japan	13	113 0.2×	52 0.1×	14 0.1×	185 2.5×	8 0.2×	53	442
Rivka Shapiro Israel	12	156 0.3×	84 0.2×	19 0.2×	194 2.6×	51 1.0×	35	496

Countries citing papers authored by Chia‐Chi Wang

Since Specialization

Citations

This map shows the geographic impact of Chia‐Chi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Chi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Chi Wang more than expected).

Fields of papers citing papers by Chia‐Chi Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Chi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Chi Wang. The network helps show where Chia‐Chi Wang may publish in the future.

Co-authorship network of co-authors of Chia‐Chi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Chi Wang. A scholar is included among the top collaborators of Chia‐Chi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Chi Wang. Chia‐Chi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tseng, Tai‐Chung, Yao‐Chun Hsu, Tung‐Hung Su, et al.. (2025). Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases. Journal of the Formosan Medical Association. 124(11). 1010–1017.

Wang, Shaowen, C. H. Wang, Yu‐Ming Cheng, et al.. (2025). Liver and atherosclerotic risk of alcohol consumption in patients with metabolic dysfunction-associated Steatotic Liver Disease. Atherosclerosis. 403. 119161–119161. 1 indexed citations

Wang, Shaowen, C. H. Wang, Yu‐Ming Cheng, et al.. (2025). Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study. Hepatology International. 19(2). 415–427. 4 indexed citations

Cheng, Yu‐Ming & Chia‐Chi Wang. (2024). Achieving global uniformity for the new name and diagnostic criteria of non-alcoholic fatty liver disease. Journal of the Formosan Medical Association. 123(6). 636–637. 2 indexed citations

Cheng, Yu‐Ming, Tsung‐Han Hsieh, Chia‐Chi Wang, & Jia‐Horng Kao. (2024). Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research. JGH Open. 8(10). 1 indexed citations

Wang, Shaowen, Tsung‐Han Hsieh, Yu‐Ming Cheng, Chia‐Chi Wang, & Jia‐Horng Kao. (2024). Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease. Hepatology International. 18(3). 943–951. 3 indexed citations

Ko, Yu‐Lin, Wei‐Chih Su, Chia‐Chi Wang, et al.. (2024). SLC10A1 rs2296651 variant (S267F mutation) predicts biochemical traits, hepatitis B virus infection susceptibility and the risk of gallstone disease. Molecular Genetics and Genomics. 299(1). 62–62.

Cheng, Yu‐Ming, Tsung‐Han Hsieh, Chia‐Chi Wang, & Jia‐Horng Kao. (2023). Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease. JHEP Reports. 5(9). 100836–100836. 8 indexed citations

Wang, Shaowen, et al.. (2023). Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease. Journal of the Formosan Medical Association. 123(1). 36–44. 10 indexed citations

10.

Cheng, Yu‐Ming, et al.. (2023). Predictors of Liver Dysfunction After Transhepatic Arterial Chemo-embolization in Hepatocellular Carcinoma Patients. Digestive Diseases and Sciences. 68(8). 3467–3472. 2 indexed citations

11.

Cheng, Yu‐Ming, et al.. (2021). Predictors of recurrence in early hepatocellular carcinoma patients treated with surgical resection. Advances in digestive medicine. 10(1). 21–27. 2 indexed citations

12.

Cheng, Yu‐Ming & Chia‐Chi Wang. (2020). Liver abscesso-colonic fistula following hepatic infarction: A rare complication of radiofrequency ablation for hepatocellular carcinoma. Journal of the Formosan Medical Association. 120(3). 1027–1028.

13.

Wang, Chia‐Chi, Kuo‐Chih Tseng, I‐Shiang Tzeng, & Jia‐Horng Kao. (2020). The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma. Journal of the Formosan Medical Association. 120(3). 965–973. 4 indexed citations

14.

Peng, Cheng‐Yuan, Tsung‐Cheng Hsieh, Kuo‐Chih Tseng, et al.. (2013). HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients. Journal of the Formosan Medical Association. 114(4). 308–313. 11 indexed citations

15.

Wang, Chia‐Chi, Tai‐Chung Tseng, Tsung‐Cheng Hsieh, et al.. (2012). Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk. The Kaohsiung Journal of Medical Sciences. 28(3). 151–160. 18 indexed citations

16.

Wang, Chia‐Chi, Ching‐Sheng Hsu, Tai‐Chung Tseng, et al.. (2009). Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 24(8). 1411–1416. 42 indexed citations

17.

Tseng, Tai‐Chung, Chun‐Jen Liu, Chia‐Chi Wang, et al.. (2008). A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine‐treated chronic hepatitis B patients. Liver International. 28(7). 1034–1041. 17 indexed citations

18.

Liu, Chen‐Hua, Chun‐Jen Liu, Chih‐Lin Lin, et al.. (2008). Pegylated Interferon‐α‐2a plus Ribavirin for Treatment‐Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial. Clinical Infectious Diseases. 47(10). 1260–1269. 152 indexed citations

19.

Chen, Fei, Chia‐Chi Wang, Eugene S. Kim, & Lawrence E. Harrison. (2008). Hyperthermia in combination with oxidative stress induces autophagic cell death in HT‐29 colon cancer cells. Cell Biology International. 32(7). 715–723. 41 indexed citations

20.

Wang, Chia‐Chi, Chun‐Jen Liu, Ming–Yang Lai, Jia‐Horng Kao, & Ding‐Shinn Chen. (2007). Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients. Liver International. 27(2). 235–239. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact